Literature DB >> 12867567

Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus.

John E Gustafson1, Frances G O'Brien1, Geoffrey W Coombs1, Mary J Malkowski1, Warren B Grubb1, Richard F Pfeltz1, Brian J Wilkinson1.   

Abstract

The ability of phage-typing and SmaI chromosomal RFLPs to conclude appropriate strain relatedness between a collection of 12 well-characterized in vitro-selected vancomycin-intermediate Staphylococcus aureus (VISA) strains and their seven vancomycin-susceptible parent strains is reported. Generally, no SmaI RFLP alterations were observed in VISA strains when they were compared with their respective parent strains, and clonal relationships between isogenic strains were clearly evident. Unlike the SmaI RFLP results, parent strains and VISA derivatives generally did not share similar phage-typing profiles. Depending on the phage set investigated, some VISA strains even became untypable by this method. Loss of phage infectivity is probably due to cell wall (phage receptor) alterations that are expressed by the VISA strains investigated. Collectively, these findings indicate that inappropriate relationships between VISA and vancomycin-susceptible parents might be drawn if only phage-typing and antibiotic susceptibility are utilized to determine epidemiological relationships.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867567     DOI: 10.1099/jmm.0.05210-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.

Authors:  Jennifer L Koehl; Arunachalam Muthaiyan; Radheshyam K Jayaswal; Kerstin Ehlert; Harald Labischinski; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus.

Authors:  Reena Lamichhane-Khadka; Stephanie A Cantore; James T Riordan; Alejandro Delgado; Alesha E A Norman; Sarah Dueñas; Shahrear Zaman; Sonia Horan; Brian J Wilkinson; John E Gustafson
Journal:  Int J Antimicrob Agents       Date:  2009-03-25       Impact factor: 5.283

3.  The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.

Authors:  Michael Hort; Ute Bertsche; Senada Nozinovic; Alina Dietrich; Anne Sophie Schrötter; Laura Mildenberger; Katharina Axtmann; Anne Berscheid; Gabriele Bierbaum
Journal:  Microbiol Spectr       Date:  2021-10-20

4.  Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA).

Authors:  Shawna McCallin; Carmen Menzi; Swenja Lassen; Jean Daraspe; Frank Oechslin; Philippe Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2022-06-16       Impact factor: 5.938

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.